Reporte de Automatización con IA para Veozah

Astellas is a global pharmaceutical enterprise specializing in the development and commercialization of innovative prescription treatments, such as VEOZAH for menopause-related symptoms. The company operates a dual-facing business model targeting both consumers (patients) and healthcare professionals (HCPs) through highly regulated marketing and clinical education channels. Their operations are characterized by significant investment in patient access programs, including financial assistance and copay support, alongside rigorous regulatory compliance and safety reporting. As a major industry player, Astellas differentiates itself through specialized treatments in women's health and advanced pharmaceutical R&D.